Introduction
Obesity has become a serious public health problem, with a growing worldwide prevalence [1] . In the past, obesity was not a common condition among China; however, this is no longer the case [2] . Besides the worrisome prevalence, obesity markedly increases the risk of developing hypertension, diabetes, and cardiovascular disease (CVD) [3] . The gold standard and most accurate assessment of subcutaneous adipose tissue (SAT) and visceral abdominal fat (VAT) is computed tomography (CT) [4] . Body mass index (BMI) was used to define overweight and obesity because it is the most common parameter used in clinical practice to assess adiposity excess. One study showed that anthropometric measures of body fat such as BMI appear to provide as consistent estimates of chronic kidney disease (CKD) risk as CT measures [5] . A recent systematic review and meta-analysis suggests that obesity acts as independent predictor of new-onset CKD, and this association persists for either albuminuric stages 1-2 without decreased renal function and stages 3 or more (with estimated filtration rate, eGFR < 60 ml/ min/1.73 m 2 ) of CKD. Renal risk is limited to the status of obesity and also persists independently from the presence of metabolic 
AbStr AC t
While obesity is a recognized risk factor for chronic kidney disease, it remains unclear whether change in body mass index (ΔBMI ) is independently associated with decline in renal function (evaluated by the change in estimated glomerular filtration rate, ΔeGFR) over time. Accordingly, to help clarify this we conducted a retrospective study to measure the association of ΔBMI with decline in renal function in Chinese adult population.
A total of 4007 adults (aged 45.3 ± 13.7 years, 68.6 % male) without chronic kidney disease at baseline were enrolled between 2008 and 2013. Logistic regression models were applied to explore the relationships between baseline BMI and ΔBMI, and rapid decline in renal function (defined as the lowest quartile of ΔeGFR ). During 5 years of follow-up, the ΔBMI and ΔeG-FR were 0.47 ± 1.6 (kg/m 2 ) and -3.0 ± 8.8 (ml/min/1.73 m 2 ), respectively. After adjusted for potential confounders, ΔBMI (per 1 kg/m 2 increase) was independently associated with the rapid decline in renal function [with a fully adjusted OR of 1.12 (95 % CI, 1.05 to 1.20) . By contrast, the baseline BMI was not associated with rapid decline in renal function [OR = 1.05 (95 % CI, 0.98 to 1.13)]. The results were robust among 2948 hypertension-free and diabetes-free participants, the adjusted ORs of ΔBMI and baseline BMI were 1.14 (95 % CI, 1.05 to 1.23) and 1.0 (95 % CI, 0.96 to 1.04) for rapid decline in renal function, respectively. The study revealed that increasing ΔBMI predicts rapid decline in renal function.
syndrome, conversely, overweight did not predict incidence of CKD [6] . But another recent study provides direct evidence that being overweight, not being obese, increases risk of rapid annual eGFR decline; And also the result suggested a nonlinear S-shaped association between BMI and annual eGFR decline [7] . In normal physiology, GFR declines with aging by approximately 0.8 ml/min/1.73 m 2 annually [8] . A decreased eGFR is a risk factor of CVD [9, 10] and is associated with CVD mortality and morbidity in both high-risk patients [11, 12] and the general population [13] . Rapid GFR decline, an early and progressive decline in GFR, is thought to be an early marker of progressive kidney disease, and has also been shown to be associated with CVD and all-cause mortality [14] . It remains unclear what initiates rapid GFR decline. While hypertension and aging are well-known risk factors for the progression of renal impairment [15] , the effects of excess body weight and weight change over time on kidney function remain to be explored. Furthermore, although several studies had explored the role of BMI in the development of renal impairment in white and black population [16] [17] [18] , few studies have assessed the relationship whether change in BMI (ΔBMI ) contributes to the progression of renal function deterioration as an independent risk factor, especially among Chinese adult population. Accordingly, to help clarify this we conducted a retrospective study to measure the association of ΔBMI with decline in renal function in subjects without CKD at baseline.
Subjects and Methods

Study population
This study was a single-center retrospective cohort study. We analyzed the medical records of study subjects from the database who underwent annual medical examination in a large tertiary-care university hospital between 2008 and 2013. Those participants come from all over Jinan to receive a regular paid health examination. Participants with proteinuria and with decreased eGFR ( < 60 ml/ min/1.73 m 2 ) in the baseline were excluded. Patients with malignant disease, heart failure, severe liver disease, infection disease, and pregnancy were also excluded. In all, a total of 4007 adults with the whole medical records were enrolled and they were followed for 5 years. The ethics committee of Qianfoshan Hospital approved the study. All participants gave written informed consent prior to data collection.
Data collection
Blood was collected by means of venupuncture after an overnight fast of at least 10 h. Serum creatinine was measured by means of using the Roche enzymatic method on an automatic biochemistry analyzer (Roche P Modular with Roche Creatininase Plus assay, Hoffman-La Roche, Ltd.). eGFR was calculated using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) two-level race equation [19, 20] . Protein in urine was measured on a morning urine sample using an immediate semiquantitative urine protein dipstick test and graded as negative, trace, 1 + , 2 + , 3 + , or 4 + . Subjects were considered to be proteinuric by repeated measures if their urinalysis showed ≥ 1 + on both initial and follow-up studies 1 or 2 weeks apart. Participants with pyuria were excluded from the analysis of proteinuria due to concern of urinary tract infection. Women during menstruation were asked to receive urine routine test 3 days after menstruation. Decreased renal function was defined as the eGFR < 60 ml/ min/1.73 m 2 . Hemoglobin, urea nitrogen, fasting blood glucose, serum uric acid, serum total cholesterol (TC), and triglycerides (TG) were also measured by the automatic biochemistry analyzer.
Sociodemographic characteristics, health history (e.g, hypertension, diabetes), and lifestyle behaviors were obtained through questionnaire. Diabetes was defined as fasting blood glucose ≥ 7.0 mmol/l or by the use of hypoglycemic agents or by self-reported history of diabetes. Blood pressure was measured thrice and were taken at 5-min intervals. The mean of the three readings was calculated, unless the difference between the readings was greater than 10 mmHg, in which case the mean of the two closest measurements was used. Hypertension was defined as systolic blood pressure of more than 140 mm Hg or diastolic blood pressure of more than 90 mm Hg, or both, or patients already being prescribed by antihypertensive medicaments. The BMI was calculated from body weight measured with light clothing to the nearest 0.1 kg and body height without shoes to the nearest 0.5 cm.
All of the investigators have completed a training program of the methods and procedures of the study.
Outcomes
The BMI and eGFRs were re-evaluated using the same strategy after 5 years follow up. The 2013 BMI was calculated from body weight measured with light clothing to the nearest 0.1 kg and body height without shoes to the nearest 0.5 cm. Serum creatinine was measured by means of using the Roche enzymatic method again and 2013 eGFR was calculated using the CKD-EPI equation [19, 20] . Change in body mass index (ΔBMI = 2013 BMI-baseline BMI ) and decline in renal function (evaluated by the change in eGFR, ΔeGFR = 2013 eGFR-baseline eGFR) were calculated. Rapid decline in renal function was defined as the lowest quartile of ΔeGFR. CKD was defined as decreased eGFR < 60 ml/min/1.73 m 2 or presence of proteinuria (urine protein ≥ 1 + ) assessed using a repeated dipstick method.
Statistical Analysis
Data are presented as proportions for categorical variables and mean ± SD or median [interquartile range (IQR)] for continuous variables. The significance of differences in continuous variables among four groups (quartile of ΔBMI) were tested using one-way analysis of variance. The difference in the distribution of categorical variables was tested using Chi-square test. Univariate and multivariate logistic regression analysis were used to estimate risk factors associated with rapid decline in renal function. Independent variables included age, sex, hypertension, diabetes, smoking, uric acid, total cholesterol, triglycerides, baseline BMI, and ΔBMI. The upper quartile of baseline BMI was also used as a categorical dependent variable for analyses, in comparison with the lower three quartiles. The 25, 50, and 75 percentile of BMI was 22.4, 24.6, and 26.8 kg/m 2 , respectively. The correlation between ΔBMI and ΔeGFR over 5 years was evaluated by Pearson's correlation. In our secondary analysis, subgroup participants without hypertension and without diabetes were included (n = 2948). Then the same logistic regression model was built to estimate the associations between baseline BMI and ΔBMI and rapid decline in renal function.
Crude and adjusted odds ratios (ORs) with 95 % confidence interval (CI) were reported. All analyses were performed by SPSS statistical package, version 16.0 (SPSS, Inc., Chicago, IL, USA). All p-values are two tailed. A p-value of less than 0.05 is considered statistically significant.
Results
Among 4007 participants in the study, the mean age was 45.3 ± 13.7 years (range 18-84 years), and 68.6 % of them were males. The mean baseline BMI and eGFR were 24.71 ± 3.37 (kg/m 2 ) and 98.4 ± 14.2 ml/min/1.73 m 2 . Baseline characteristics of the participants stratified according to the quartiles of ΔBMI are shown in ▶ table 1. Among all participants, subjects in the highest quartile of ΔBMI group tended to be younger, lower percentage of hypertension and diabetes, lower baseline BMI and higher baseline eGFR (p < 0.05).
During 5 years of follow-up, 158 (3.9 %) patients developed CKD, 108 (2.7 %) patients with proteinuria and 56 (1.4 %) patients with decreased eGFR. The ΔBMI and ΔeGFR were 0.47 ± 1.6 (kg/m 2 ) and -3.0 ± 8.8 (ml/min/1.73 m 2 ) in all participants, respectively. The ΔBMI and ΔeGFR were 0.3 ± 1.6 (kg/m 2 ) and -7.8 ± 12.9 (ml/ min/1.73 m 2 ) in 158 CKD patients, respectively. Rapid decline in renal function was defined as the lowest quartile of ΔeGFR in the study. In fact, the changes of eGFR in the lowest quartile based on eGFR change was -14.3 ml/min/1.73 m 2 in 5 years. Subjects in the highest quartile of ΔBMI group had higher change in BMI and eGFR than other three groups (p < 0.001) (▶ table 1) .
Pearson correlation analysis revealed the inverse correlations between ΔBMI and ΔeGFR for 5 years [y = (-0.102)x -6.47, p < 0.001] (▶ Fig. 1) . We analyzed the ORs of variables associated with rapid decline in renal function. In the univariate logistic regression analysis, ΔBMI (per 1 kg/m 2 increase) were independently associated with increased risks of rapid decline in renal function, with 558 ▶table 1 Clinical characteristics of participants stratified according to the quartiles of ΔBMI. . In our secondary analysis, subgroup participants without hypertension and without diabetes were included (n = 2948). The results were also robust among hypertension-free and diabetes-free participants, the adjusted ORs of ΔBMI and baseline BMI were 1.14 (95 % CI, 1.05 to 1.23) and 1.0 (95 % CI, 0.96 to 1.04) for rapid decline in renal function, respectively (▶table 2).
Discussion
A progressive decrease in renal function has a widespread effect on health, including the functioning of the heart and brain; hormonal balance, anemia, and bone and mineral metabolism; and ability to resist infections. In the retrospective cohort study, the mean BMI levels increased from 24.71 ± 3.37 kg/m 2 to 25.17 ± 3.33 kg/m 2 and mean eGFR decreased from 98.4 ± 14.2 to 95.4 ± 15.0 ml/ min/1.73 m 2 over 5 years. It has been shown that weight gain was associated with the development of CKD, even in non-obese subjects [21] . The study of the PRVED determined the effect of weight change on the change in urine albumin excretion during the average period of 4.2 years. Subjects with weight gain more than 10 kg were associated with an increase in urine albumin excretion, whereas those with weight loss more than 10 kg showed a reduction of eGFR: Estimated glomerular filtration rate; OR: Odds ratio; CI: Confidence interval; BMI: Body mass index; * OR was adjusted for age and sex; † OR was adjusted for age, sex, hypertension, diabetes, smoking, uric acid, total cholesterol, triglycerides, baseline BMI, and ΔBMI; ΔBMI = 2013 BMI-baseline BMI; ‡ Subgroup, n = 2948, included participants without hypertension and without diabetes. The multivariable adjusted OR was adjusted for age, sex, smoking, uric acid, total cholesterol, triglycerides, baseline BMI, and ΔBMI.
urine albumin excretion [22] . A more recent (2004-2006) study of 3.3 M United States (US) veterans reported "U"-shaped associations between BMI and risk of rapid decline in renal function [23] . However, the most important observation in this study was that after adjusted for potential confounders, not baseline BMI, but ΔBMI was independently associated with increased risk of rapid decline in renal function [with a fully adjusted OR of 1.12 (95 % CI, 1.05 to 1.20) ]. In addition, in our secondary analysis, the results were also robust among hypertension-free and diabetes-free participants, the adjusted OR of ΔBMI was 1.14 (95 % CI, 1.05 to 1.23) for rapid decline in renal function. The mechanisms by which weight gain may initiate and exacerbate rapid decline in renal function remain elusive. Obese patients are at a higher risk for focal segmental glomerulosclerosis and glomerulomegaly [24] , and almost half of patients rapidly develop advanced renal failure [25] . Obesity-related kidney damage is thought to initiate with a hyperfiltration phase, however, a contribution of inflammatory and metabolic mechanisms can be hypothesized [26, 27] . More recently, the recognition that adipose tissue is involved in the production of several bioactive molecules, such as adiponectin, leptin, inflammatory, and oxidative stress markers, even in children [28, 29] , and that many of those substances may affect the cells in the renal glomeruli and cause pathological changes [27] . It has been speculated that the production of active fibrotic cytokines recognized in several kidney diseases as markers of disease activity and histopathological deterioration, might also be increased in the set of obesity [30] . Abnormal activation of RAS, which occurs despite sodium retention and expansion of fluid volume is common in obese individuals [31] and may directly account for glomerular hypertension and onset of proteinuria. Interestingly, the role of RAS might persist in overt CKD; in agreement with this hypothesis, a post hoc analysis of the REIN study in CKD patients showed that use of RAS inhibitors allowed a greater nephroprotection in obese versus nonobese participants [32] .
Obesity, along with hypertension, impaired glucose tolerance or diabetes mellitus and dyslipidemia are well-known factors of metabolic syndrome. Together, they increase the risk of CVD and CKD. In the study, participants with CKD in the baseline were excluded, the result showed that diabetes was inversely correlate with rapid decline in renal function after adjusted for confounders, with the OR of 0.63 (95 % CI, 0.43-0.94). The possible mechanism for the hyperfiltration was characterized by the increase of eGFR caused by insulin resistance in diabetes [33] .
We found that weight gain was a significant predictor of decline in renal function, so weight loss intervention especially in overweight or obese subjects could be therefore considered as a main strategy to limit the deterioration of renal function in the general population. One study showed that obesity-related glomerular hyperfiltration ameliorates after weight loss. The improvement in hyperfiltration may prevent the development of overt obesity-related glomerulopathy [34] . In smaller, short-duration studies in patients with CKD, nonsurgical weight loss interventions reduce proteinuria and seem to prevent further decline in renal function [35] . The importance of this preventive approach grows when considering that once CKD has developed, the role of abnormal BMI on progression of CKD becomes less evident [35] [36] [37] . A recent meta-analysis found that modest nonsurgical weight loss did not improve creatinine-based estimates of GFR in those with significantly decreased renal function, suggesting that weight loss may have been too late to improve renal function or that a threshold effect for weight loss intervention may exist [35] . Further study is needed to determine the effect of various degrees of weight loss on reversing or stabilizing potential obesity-related declines throughout the spectrum of renal function.
This study possesses some limitations. First, this study was a retrospective, single center study, which may introduce selection bias. However, an important strength of a single-center study is the lack of inter-laboratory variability. Second, increasing BMI cannot accurately distinguish increasing fat tissues from muscle mass changes. Third, we did not account for medication use for study subjects.
Medications and altered renal handling may affect renal function. Moreover, we used a single morning sport urine sample to assess proteinuria, instead of urinary albumin-to-creatinine ratio, which would be more preferable. Finally, single measurements of serum creatinine at baseline and serum creatinine after 5 years could have resulted in the misclassification of exposure, confounders, and outcomes. Also, GFR was not directly measured using the gold-standard method of inulin clearance but was instead estimated with a serum creatinine-based equation. This could have over-or underestimated the actual GFR in the population. However, the association observed in the current study could not be attributed to this source of variability because random misclassification of this type would be likely to cause underestimation of study findings and bias results toward the null hypothesis.
In conclusion, the study revealed that increasing ΔBMI predicts rapid decline in renal function. Although weight loss seems to produce renal benefits in those obese CKD patients, current evidence is still sparse and limited, which prevents definitive conclusions for recommending specific interventions. Future, high-quality studies focusing on hard outcomes such as rapid decline in renal function or kidney failure are needed to clarify whether intentional weight loss offers additional benefits to the renal, as well as the cardiovascular risk profile in the long term.
